Collegium Pharmaceutical (COLL) Common Equity (2014 - 2026)
Collegium Pharmaceutical (COLL) posted quarterly Common Equity of $312.4 million for Q1 2026, up 33.27% year-over-year from $234.4 million in Q1 2025, and up 3.56% quarter-over-quarter from $301.7 million in Q4 2025.
Collegium Pharmaceutical (COLL) Common Equity (2014 - 2026) Analysis & Trends
Collegium Pharmaceutical's Common Equity history runs 13 years deep, the most recent figure standing at $312.4 million for Q1 2026.
- In Q1 2026, Common Equity rose 33.27% year-over-year to $312.4 million; the TTM figure through Mar 2026 stood at $312.4 million (up 33.27% YoY), while the FY2025 annual figure was $301.7 million, up 31.83% from the prior year.
- Common Equity for Q1 2026 stood at $312.4 million, up from $301.7 million in the prior quarter.
- The five-year high for Common Equity was $312.4 million in Q1 2026, with the low at $178.9 million in Q3 2023.
- The 5-year median for Common Equity is $216.6 million (2024), against an average of $223.4 million.
- The sharpest annual moves came in 2022 and 2026: Common Equity retreated 21.91% in 2022, then surged 33.27% in 2026.
- Collegium Pharmaceutical's Common Equity stood at $194.8 million in 2022, then advanced by 0.3% to $195.4 million in 2023, then advanced by 17.1% to $228.8 million in 2024, then soared by 31.83% to $301.7 million in 2025, then climbed by 3.56% to $312.4 million in 2026.
- Business Quant data shows COLL's Common Equity at $312.4 million in Q1 2026, $301.7 million in Q4 2025, and $274.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 22.06 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 7.76 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 3.15 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 47.42 Bn |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 6.40 Bn |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | 14.26 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 3.69 Bn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 6.59 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 4.05 Bn |
| 10 | Collegium Pharmaceutical | 889.49 Mn | 740.17 Mn | 110.29 Mn | 311.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 311.91 Mn |
| Mar 31, 2026 | 312.42 Mn |
| Dec 31, 2025 | 301.68 Mn |
| Sep 30, 2025 | 274.81 Mn |
| Jun 30, 2025 | 232.21 Mn |
| Mar 31, 2025 | 234.43 Mn |
| Dec 31, 2024 | 228.84 Mn |
| Sep 30, 2024 | 234.28 Mn |
| Jun 30, 2024 | 216.58 Mn |
| Mar 31, 2024 | 222.17 Mn |
| Dec 31, 2023 | 195.43 Mn |
| Sep 30, 2023 | 178.87 Mn |
| Jun 30, 2023 | 200.81 Mn |
| Mar 31, 2023 | 179.73 Mn |
| Dec 31, 2022 | 194.84 Mn |
| Sep 30, 2022 | 197.19 Mn |
| Jun 30, 2022 | 197.61 Mn |
| Mar 31, 2022 | 196.08 Mn |
| Dec 31, 2021 | 202.93 Mn |
| Sep 30, 2021 | 251.09 Mn |